未登录 分享 收藏
分享 收藏
分享 收藏
Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced Merkel Cell Carcinoma 晚期 Merkel Cell Carcinoma 患者接受抗 PD-(L)1 疗法后进展性疾病的治疗结果与管理 Mo, Jeremy; Zaremba, Anne; Inderjeeth, Andrisha-Jade; El Zeinaty, Perla; Li, Ao; Wicky, Alexandre; Della Marta, Nicholas; Marqueste, Caroline Gaudy; Bohne, Ann-Sophie; Matias, Margarida; McNamee, Nicholas; Festino, Lucia; Chen, Charley; Ch'ng, Sydney; van Akkooi, Alexander C. J.; Da Meda, Laetitia; Park, John J.; Ascierto, Paolo A.; Hauschild, Axel; Lee, Jenny H.; Grob, Jean Jacques; Mangana, Joanna; Guminski, Alex; Michielin, Olivier; Xu, Wen; Lebbe, Celeste; Sandhu, Shahneen; Zimmer, Lisa; Menzies, Alexander M.; Lo, Serigne N.; Long, Georgina V.; Carlino, Matteo S.; da Silva, Ines Pires 分享 收藏
Updated efficacy and safety of SHR-A1811, an anti-HER2 antibody-drug conjugate, in heavily pretreated advanced solid tumors with HER2-expression or mutations: a global, multicenter, phase 1 study SHR-A1811，一种抗HER2抗体药物偶联物，在HER2表达或突变的重度预治晚期实体瘤中的更新疗效与安全性：一项全球、多中心、I期研究 Yao, H.; Yan, M.; Tong, Z.; Wu, X.; Yin, Y.; Ryu, M. -h.; Park, J. J.; Dai, T.; Zhao, Y.; Kim, J. H.; Wang, S.; Zhong, Y.; Voskoboynik, M.; Zhang, J.; Kaubisch, A.; Liu, C.; Chen, Y.; Im, S. -a.; Wu, L.; Liu, Y.; Ganju, V.; Barve, M.; Li, H.; Yao, G.; Bao, L.; Teng, Y.; Qian, J.; Zhou, H.; Zhao, J.; Zhao, K.; Shen, Y.; Rong, S.; Zhu, X.; Song, E. 分享 收藏
Incidental pulmonary nodules; eliminating the risk of missing early lung cancer Thakrar, Vedas; Wolos, Maria; Yates, Joanne; Falolu, Adedamola; Duong, Yen; Ridgeon, Claire; Benamore, Rachel; Park, John; Moore, Alastair; Talwar, Ambika 分享 收藏
Results from monotherapy dose escalation of MDNA11, a long-acting IL-2 superkine, in a phase 1/2 trial show evidence of single-agent activity in advanced solid tumors Atkinson, Victoria G.; Antras, Jesus F.; Bedard, Philippe; Brenner, Warren; Brown, Jacqueline; Lemech, Charlotte R.; Lloyd, Peter; Margolin, Kim; Mathew, Matthen; Park, John J.; Thomas, Sajeve; Twardowski, Przemyslaw; Gardner, Humphrey; Prawira, Amy; Coello, Melissa; Ebrahimimizadeh, Walead; To, Minh D.; Merchant, Rosemina; Karanam, Sudhir Madduri; Yavari, Arash; Siu, Lillian L.; Tawbi, Hussein A.; Ascierto, Paolo A. 分享 收藏
Safety and efficacy of JSKN003 in patients with advanced/metastatic solid tumors: A first-in-human, dose-escalation, multicenter, open-label, phase I study Beecroft, Claire; Gao, Bo; Park, John; Wilkinson, Kate; Zhang, Karl; Yan, Xiangyun; Lv, Yuan 分享 收藏
A phase 1 study of D3S-001, a second-generation GDP-bound KRAS G12C inhibitor, as monotherapy in patients with KRAS G12C-mutated solid tumors Cho, Byoung Chul; Lu, Shun; Lee, Myung Ah; Song, Zhengbo; Park, John; Lim, Sun Min; Li, Ziming; Zhao, Jun; Richardson, Gary; Zhang, Yanqiao; Zhang, Jun; Liu, Anwen; Chen, Cheng; Wang, Jia; Lu, Jingtao; Rui, Haopeng; Chen, Qian; Wang, Hui; Zhang, Jing; Chen, Zhi Jian; Mok, Tony 分享 收藏
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice Duechs, Matthias J.; Kratzer, Ramona F.; Vieyra-Garcia, Pablo; Strobel, Benjamin; Schoenberger, Tanja; Gross, Peter; Aljayyoussi, Ghaith; Gupta, Aradhana; Lang, Isabel; Klein, Holger; Morilla, Sandra Martinez; Hopf, Stefan; Park, John; Kreuz, Sebastian; Klugmann, Matthias; Igney, Frederik H. 分享 收藏
分享 收藏
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study McLean, Luke S.; Lim, Annette M.; Bressel, Mathias; Lee, Jenny; Ladwa, Rahul; Guminski, Alexander D.; Hughes, Brett; Bowyer, Samantha; Briscoe, Karen; Harris, Samuel; Kukard, Craig; Zielinski, Rob; Alamgeer, Muhammad; Carlino, Matteo; Mo, Jeremy; Park, John J.; Khattak, Muhammad A.; Day, Fiona; Rischin, Danny 分享 收藏
Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer Umashankar, Saumya; Li, Moming; Blevins, Kaylee; Kim, Mi-Ok; Majure, Melanie; Park, John; Huppert, Laura A.; Melisko, Michelle; Rugo, Hope S.; Esserman, Laura; Chien, A. Jo 分享 收藏
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer Gumusay, Ozge; Huppert, Laura A.; Magbanua, Mark Jesus M.; Wabl, Chiara A.; Assefa, Michael; Chien, Amy Jo; Melisko, Michelle E.; Majure, Melanie C.; Moasser, Mark; Park, John; Rugo, Hope S. 分享 收藏
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer Day, Daphne; Park, John J.; Coward, Jermaine; Markman, Ben; Lemech, Charlotte; Kuo, James C.; Prawira, Amy; Brown, Michael P.; Bishnoi, Sarwan; Kotasek, Dusan; Strother, R. Matthew; Cosman, Rasha; Su, Rila; Ma, Yiding; Yue, Zenglian; Hu, Hui-han; Wu, Rachel; Li, Peiqi; Tse, Archie N. 分享 收藏
Interim results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody®) monotherapy and in combination with toripalimab (an anti-PD-1 antibody) in patients (pts) with advanced/metastatic solid tumors Ariyapperuma, Mihitha; Park, John J.; Khattak, Adnan; Richardson, Gary; Hamid, Anis; Morris, Michelle; Tolcher, Anthony W.; Goh, Boon Cher; Lam, Justina; Chmielowski, Bartosz; She, Kristine; Zhang, Yanyan; Li, Ai; Zheng, Songmao; Liu, Guizhong; Zhu, Lvyu; Wang, Hongyan; Cui, Xiaoxing; Luo, Peter; Zha, Jiping 分享 收藏
Safety, tolerability, pharmacokinetics, and antitumor activity of SHR-A1811 in HER2-expressing/mutated advanced solid tumors: A global phase 1, multi-center, first-in-human study Yao, Herui; Yan, Min; Tong, Zhongsheng; Wu, Xinhong; Ryu, Min-Hee; Kim, Jee Hyun; Park, John; Zhong, Yahua; Han, Weiqing; Liu, Caigang; Voskoboynik, Mark; Qin, Qun; Zhang, Jian; Barve, Minal; Acuna-Villaorduna, Ana; Ganju, Vinod; Im, Seock-Ah; Ye, Changsheng; Yin, Yongmei; Roy, Amitesh C.; Bai, Li-Yuan; Lin, Yung-Chang; Yen, Chia-Jui; Li, Hui; Chung, Ki Young; Gu, Shanzhi; Qian, Jun; Teng, Yuee; Chen, Yiding; Shen, Yu; Zhao, Kaijing; Rong, Shangyi; Zhu, Xiaoyu; Song, Erwei 分享 收藏
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel Solanki, Abhishek A.; Puckett, Lindsay L.; Kujundzic, Ksenija; Katsoulakis, Evangelia; Park, John; Kapoor, Rishabh; Hagan, Michael; Kelly, Maria; Palta, Jatinder; Ballas, Leslie K.; DeMarco, John; Hoffman, Karen E.; Lawton, Colleen A. F.; Michalski, Jeff; Potters, Louis; Zelefsky, Michael; Kudner, Randi; Dawes, Samantha; Wilson, Emily; Sandler, Howard 分享 收藏
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma Piperno-Neumann, S.; Carlino, M. S.; Boni, V.; Loirat, D.; Speetjens, F. M.; Park, J. J.; Calvo, E.; Carvajal, R. D.; Nyakas, M.; Gonzalez-Maffe, J.; Zhu, X.; Shirley, M. D.; Ramkumar, T.; Fessehatsion, A.; Burks, H. E.; Yerramilli-Rao, P.; Kapiteijn, E. 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
